HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yonggang Tu Selected Research

Yonggang Tu Research Topics

Disease

5Colitis
04/2024 - 12/2018
4Inflammation (Inflammations)
04/2024 - 01/2019
4Weight Loss (Weight Reduction)
09/2022 - 12/2018
3Dysbiosis
04/2024 - 02/2019
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
04/2024 - 12/2018
1Necrosis
01/2023
1Stomach Diseases
01/2023
1Dehydration (Water Stress)
09/2022
1Cheilitis
06/2021
1Fissure in Ano (Anal Fissure)
06/2021
1Hypertrophy
12/2018
1Pain (Aches)
01/2017

Drug/Important Bio-Agent (IBA)

4CytokinesIBA
04/2024 - 12/2018
3LipidsIBA
04/2024 - 09/2022
3Dextran SulfateIBA
04/2024 - 09/2022
3Peptides (Polypeptides)IBA
09/2022 - 12/2018
2InflammasomesIBA
04/2024 - 11/2023
2LipopolysaccharidesIBA
04/2024 - 11/2023
2Volatile Fatty AcidsIBA
04/2024 - 11/2023
2Dextrans (Dextran)FDA Link
10/2023 - 12/2018
2sodium sulfate (sodium bisulfate)FDA LinkGeneric
10/2023 - 12/2018
2Proteins (Proteins, Gene)FDA Link
08/2023 - 09/2022
2ConalbuminIBA
01/2023 - 02/2019
2Interleukin-6 (Interleukin 6)IBA
09/2022 - 12/2018
2SaltsIBA
09/2022 - 09/2022
2ML 7IBA
01/2019 - 12/2018
1N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA
04/2024
1Interleukin-18 (Interleukin 18)IBA
04/2024
1Anti-Bacterial Agents (Antibiotics)IBA
04/2024
1Mucin-2IBA
11/2023
1Phosphatidylcholines (Phosphatidylcholine)IBA
10/2023
1EnzymesIBA
08/2023
1ImmunosorbentsIBA
08/2023
1RNA (Ribonucleic Acid)IBA
08/2023
1Interleukin-10 (Interleukin 10)IBA
01/2023
1Tumor Biomarkers (Tumor Markers)IBA
01/2023
1Dinoprostone (PGE2)FDA Link
01/2023
1Interleukin-4 (Interleukin 4)IBA
01/2023
1InterleukinsIBA
01/2023
1OilsIBA
06/2021
1ParaffinIBA
05/2021
1NitrogenIBA
06/2020
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2019
1Interleukin-17 (Interleukin 17)IBA
12/2018

Therapy/Procedure

2Therapeutics
04/2024 - 11/2023
1Fecal Microbiota Transplantation
04/2024
1Chinese Traditional Medicine (Traditional Chinese Medicine)
06/2021
1Bone Wires
01/2017